single shot interscalene brachial plexus with dexmedetomidine added to ropivacaine for Anesthesia
Study Summary
This trial shows that a single-shot interscalene block with perineural dexmedetomidine can improve post-op pain relief in arthroscopic shoulder surgeries.
- Anesthesia
- Postoperative Pain
- Shoulder Pain
Treatment Effectiveness
Phase-Based Effectiveness
Study Objectives
1 Primary · 14 Secondary · Reporting Duration: 72 hours
Trial Safety
Phase-Based Safety
Awards & Highlights
Trial Design
2 Treatment Groups
continuous interscalene brachial plexus block with ropivacaine
1 of 2
single shot interscalene brachial plexus with dexmedetomidine added to ropivacai...
1 of 2
Active Control
Experimental Treatment
96 Total Participants · 2 Treatment Groups
Primary Treatment: single shot interscalene brachial plexus with dexmedetomidine added to ropivacaine · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 0 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are any additional participants needed for this investigation?
"Clinicaltrials.gov currently lists this medical trial as actively recruiting patients, in spite of its initial posting date on August 23rd 2022 and latest edit done on March 7th 2023." - Anonymous Online Contributor
What is the numerical scope of participants in this medical research endeavor?
"Affirmative. Clinicaltrials.gov records illustrate that since August 23rd 2022, this clinical trial has been actively recruiting participants from a single location to fill 96 patient spots." - Anonymous Online Contributor